ESC Premium Access

ICD implantation and device therapy: Fabry vs hypertrophic cardiomyopathy

Congress Presentation

About the speaker

Doctor Ravi Vijapurapu

University Hospital North Midlands, Stoke on Trent (United Kingdom of Great Britain & Northern Ireland)
0 follower

5 more presentations in this session

Long-term efficacy and safety of hydroquinidine in patients with Brugada syndrome

Speaker: Doctor F. Angelini (Turin, IT)


Splice site mutation of LMNA causes severe dilated cardiomyopathy via strong dominant reduction of total lamin expression

Speaker: Doctor K. Kato (Otsu, JP)


Role of an extensive diagnostic work-up in the detection of concealed cardiomyopathies in athletes with premature ventricular complexes and implications for sports' eligibility assessment

Speaker: Doctor P. Compagnucci (Ancona, IT)


KCNQ1 V141M and Short QT Syndrome: Are we dealing with a different entity?

Speaker: Doctor G. Garcia Ordonez (Ciudad de Mexico, MX)


Molecular mechanism of a new cardiac syndrome associated with a regulatory element deletion of chromosome 4q25

Speaker: Ms M. Baudic (Nantes, FR)


Access the full session

Risk of Sudden Cardiac Death in Patient with Ion Channel Disorders

Speakers: Doctor R. Vijapurapu, Doctor F. Angelini, Doctor K. Kato, Doctor P. Compagnucci, Doctor G. Garcia Ordonez...

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb